Expression Table for this CRE
| CNhs14498 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2 | 2603.5 |
| CNhs12229 | pituitary gland, adult, donor10252 | 66.4 |
| CNhs14489 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2 | 44.3 |
| CNhs13841 | iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2 | 44.1 |
| CNhs11725 | argyrophil small cell carcinoma cell line:TC-YIK | 41.6 |
| CNhs12060 | Skeletal Muscle Cells, donor6 | 39.3 |
| CNhs12657 | MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2 | 35.7 |
| CNhs12664 | MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 34.7 |
| CNhs12662 | MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2 | 34.5 |
| CNhs12656 | MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2 | 33.3 |
| CNhs12663 | MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2 | 32.6 |
| CNhs12052 | Fibroblast - Dermal, donor4 | 32.4 |
| CNhi10525_AGT | Human primary dermal fibroblasts derived from neonatal foreskin, biol_rep1 | 29.6 |
| CNhs14496 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3 | 28.8 |
| CNhs11718 | mesenchymal stem cell line:Hu5/E18 | 28.4 |
| CNhs11680 | lung, fetal, donor1 | 23.7 |
| CNhs12666 | MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2 | 23.6 |
| CNhs13434 | mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1 | 23.6 |
| CNhs14492 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2 | 23.5 |
| CNhs14490 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3 | 23.2 |
| CNhs12061 | Fibroblast - Cardiac, donor6 | 23.1 |
| CNhs12658 | MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2 | 22.5 |
| CNhs11723 | leiomyoma cell line:15242A | 22.0 |
| CNhs12659 | MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2 | 21.3 |
| CNhs12954 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2) | 20.7 |
| CNhs12654 | MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2 | 20.5 |
| CNhs14495 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2 | 20.2 |
| CNhs12665 | MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2 | 20.1 |
| CNhs11717 | oral squamous cell carcinoma cell line:HSC-3 | 19.8 |
| CNhs14595 | Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1 | 19.5 |
| CNhs12660 | MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2 | 19.4 |
| CNhs14551 | thalamus, adult, donor10258 | 19.3 |
| CNhs14497 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1 | 19.0 |
| CNhs14573 | Myoblast differentiation to myotubes, day06, control donor2 | 18.4 |
| CNhs12079 | Pericytes, donor2 | 18.1 |
| CNhs12045 | Smooth Muscle Cells - Coronary Artery, donor3 | 17.8 |
| CNhs14488 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1 | 17.5 |
| CNhs12642 | Bronchial Epithelial Cell, donor7 | 17.4 |
| CNhs12655 | MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2 | 16.7 |
| CNhs14518 | ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3 | 16.4 |
| CNhs14550 | locus coeruleus, adult, donor10258 | 16.1 |
| CNhs11715 | Hodgkin's lymphoma cell line:HD-Mar2 | 16.1 |
| CNhs12064 | Anulus Pulposus Cell, donor2 | 16.0 |
| CNhs11722 | leiomyoma cell line:10964C | 15.3 |
| CNhs11923 | Chondrocyte - de diff, donor1 | 15.0 |
| CNhs12953 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15) | 14.9 |
| CNhs12684 | K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2 | 14.9 |
| CNhs14601 | Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2 | 14.7 |
| CNhi10939_ACG | Human primary dermal blood vascular endothelial cells, biol_rep1 | 14.7 |
| CNhs11714 | chronic lymphocytic leukemia (T-CLL) cell line:SKW-3 | 14.4 |